ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OGN vs UNH // NET PROFIT MARGIN

Organon & Co. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: OGN 4 — UNH 6
▲ NET PROFIT MARGIN LEADER: UNH
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OGN VS. UNH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OGN UNH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 53.30% 88.57% -35.27 UNH /gross-margins <GO>
Return on Invested Capital (ROIC) 24.90% 11.47% +13.43 OGN /roic <GO>
EV/EBITDA & P/E Valuation — 16.4x — TIE /valuation <GO>
Free Cash Flow Yield 14.83% 6.48% +8.35 OGN /fcf-yield <GO>
Operating Margin — 4.82% — TIE /operating-margins <GO>
Net Profit Margin ACTIVE 3.00% 3.14% -0.14 UNH /net-margins <GO>
Revenue Growth (YoY) -2.90% 6.46% -9.36 UNH /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 2.43% 2.28% +0.15 OGN /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.12 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 6/9 7/9 -1.00 UNH /piotroski-score <GO>
Options Implied Move & Put/Call Skew — 6.74% — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.4 59.2 +1.20 OGN /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.33 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 18.0x 17.7x +0.26 UNH /forward-pe <GO>
Enterprise Scale & Market Cap $3.63B $368.83B -$365.20B UNH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OGN REV UNH REV OGN GROSS % UNH GROSS % OGN FCF UNH FCF
FY 2025 $6.22B $447.57B 53.3% 88.7% $538.0M $16.07B
FY 2024 $6.40B $400.28B 58.0% 88.3% $764.0M $20.70B
FY 2023 $6.26B $371.62B — 89.6% $799.0M $25.68B
FY 2022 — $324.16B — 89.6% — $23.40B
FY 2021 — $287.60B — 89.2% — $19.89B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OGN // BETA —
UNH // BETA 0.33